donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

QNRX Quoin Pharmaceuticals

4.806
-0.014-0.29%
Trading Session 08/12 14:57 ET
High
5.090
Open
4.830
Turnover
3.02M
Low
4.730
Pre Close
4.820
Volume
623.76K
Market Cap
6.90M
P/E(TTM)
Loss
52wk High
444.000
Shares
1.44M
P/E(Static)
Loss
52wk Low
3.580
Float Cap
5.23M
Bid/Ask %
47.37%
Historical High
3375.000
Shs Float
1.09M
Volume Ratio
0.11
Historical Low
3.580
Dividend TTM
--
Div Yield TTM
--
P/B
-9.46
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
57.35%
Amplitude
7.47%
Avg Price
4.842
Lot Size
1
Float Cap
5.23M
Bid/Ask %
47.37%
Historical High
3375.000
Shs Float
1.09M
Volume Ratio
0.11
Historical Low
3.580
Dividend TTM
--
P/B
-9.46
Dividend LFY
--
Turnover Ratio
57.35%
Amplitude
7.47%
Avg Price
4.842
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company’s lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
CEO: Myers Ph.D., Michael
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...